Cart
sales@molnova.com
Anthracene-9-carboxylic acid
CAS No. 723-62-6
Anthracene-9-carboxylic acid ( —— )
Catalog No. M22198 CAS No. 723-62-6
Anthracene-9-carboxylic acid is an inhibitor of chloride transport with a moderate to strong inhibitory action on PKA activated cardiac IcI.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 26 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAnthracene-9-carboxylic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnthracene-9-carboxylic acid is an inhibitor of chloride transport with a moderate to strong inhibitory action on PKA activated cardiac IcI.
-
DescriptionAnthracene-9-carboxylic acid is an inhibitor of chloride transport with a moderate to strong inhibitory action on PKA activated cardiac IcI.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCl-transport
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number723-62-6
-
Formula Weight222.24
-
Molecular FormulaC15H10O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:22.22 mg/mL (100 mM)
-
SMILESOC(=O)c2c1ccccc1cc3ccccc23
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Villegas-Navarro A, Jiménez-Salas Z, Reyes JL. Anthracene-9-carboxylic acid and haematological and biochemical variables in the rat[J]. Archives Internationales De Pharmacodynamie Et De Thérapie, 1989, 302(302):290.
molnova catalog
related products
-
Dilazep dihydrochlor...
Dilazep dihydrochloride is an adenosine uptake inhibitor. Dilazep dihydrochloride also inhibits the ischemic damage, membrane transport of nucleosides and platelet aggregation.
-
Calcium lactate
Calcium lactate is used by the beverage industry as a source of calcium to fortify fruit juice. Calcium lactate facilitates the growth and phytic acid degradation of soybean sprouts.
-
(E)-SI-2
(E)-SI-2 is a potent small-molecule inhibitor of steroid receptor coactivator-3 (SRC-3 or AIB1) that can selectively inhibit the intrinsic transcriptional activities of SRC-3, also inhibits SRC-1 and SRC-2.
